Lucknow Speciality Pharma

Dacomitinib Tablets 30 mg
Dacomitinib Tablets is used to treat a certain type of non-small-cell lung cancer (NSCLC) that has spread to other parts of the body. Dacomitinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply. To get access, please contact Patient Support Team @ +91 9760014849 / 9555306364 / 9794360370 / 9140551027, Time 9 am - 8 pm IST or send us a request on email (urgent@lucknowpharma.com) / WhatsApp for the same.
Get Access Price
WhatsApp

Dacomitinib Tablets was approved for medical use in the United States in 2018. It is on the World Health Organization’s List of Essential Medicines.

Dacomitinib Tablets Available Price In Lucknow Banaras Nepal

Dacomitinib Tablets

  • Generic Brand Available – VIZIMPRO
  • API – Dacomitinib
  • Packaging – 30 Tablets
  • Strength – 30 mg, 45 mg

What is Dacomitinib Tablets used for?

Dacomitinib Tablets is used to treat a certain type of non-small-cell lung cancer (NSCLC) that has spread to other parts of the body. Dacomitinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply.

    About Us

    Lucknow Speciality Pharma is dedicated to delivering life-changing healthcare solutions. As a trusted wholesale supplier of specialized medicines, we cater to critical care areas such as oncology, nephrology, and rare diseases. Our patient-centric approach also includes personalized catering services, ensuring that patients receive the care, support, and nutrition they need to thrive. We also extend our services globally, welcoming international patients and buyers who seek our expertise and high-quality products.

    Lucknow Speciality Pharma is a registered Pharmaceutical Firm in Lucknow, India. Registered under GST Act. Registration Number : 09AAOPG3102HIZY. It provide assistance and connectivity with drug pharmacies or distributors for access to genuine medicines at competitive prices. 

    Get Access To Dacomitinib Tablets 30 mg

    Enter Buying Requirements Details

    For precise quotations, kindly ensure your requirements include the product name, order quantity, intended usage, and any special requests you may have.

    Branch Offices in India : Lucknow | Agra | Varanasi | Gorakhpur | Kanpur | Indore | Patna | Kolkata | Nepal

    FAQs – Medicine Questions

    Dacomitinib Tablets 30 mg
    What is Dacomitinib?
    Dacomitinib is used to treat a certain type of non-small-cell lung cancer (NSCLC) that has spread to other parts of the body. Dacomitinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply.
    What are ruxolitinib tablets used for?
    Ruxolitinib is used to treat myelofibrosis (a cancer of the bone marrow in which the bone marrow is replaced by scar tissue and causes decreased blood cell production)
    Is ruxolitinib a chemo drug?

    Jakafi is the first medicine approved by the Food and Drug Administration (FDA) for the treatment of these patients. Jakafi is not chemotherapy. It is a targeted treatment that works to help keep the production of blood cells under control.

    Where can I buy Dacomitinib Tablets?

    You can buy Dacomitinib Tablets from any authorized whole-seller after getting a prescription from a qualified doctor. It is always better to check the credential of the whole-seller/supplier/exporter before buying the product.

    The buyer should check the existing law in their home country before importing the product.

    What is the procedure to buy Dacomitinib Tablets?

    Patients can simply fill the order form or can send mail at info@lucknowpharma.com Patients can also send WhatsApp messages to +91-9555306364 We will reply ASAP with the details of the Dacomitinib Tablets price as well as procurement procedure.

    Note:- The order will be confirmed only after the receipt of the Valid prescription of the Clinician.

    What is VIZIMPRO used for?
    VIZIMPRO is indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 19 deletion or exon 21 L858R substitution mutations as detected by an FDA-approved test

    NEWS / UPDATES

    1. Pfizer Limited, Electronic medicines compendium (emc), [Revised on Jan 2021] [ Accessed on 2nd Dec 2021], https://www.medicines.org.uk/emc/files/pil.10354.pdf
    2. Pfizer Labs, US Food and Drug Administration, [Revised on Sept 2018] [ Accessed on 2nd Dec 2021], https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/211288s000lbl.pdf
    3. Sally CM Lau et al; Dacomitinib in the Management of Advanced Non-Small-Cell Lung Cancer; Drugs; Published on June 2019; Accessed on 02/12/2021; https://pubmed.ncbi.nlm.nih.gov/31069718/